Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


01.01.2024

2 Am J Kidney Dis
2 Ann Neurol
3 J Autoimmun
12 J Clin Endocrinol Metab
2 J Neuroimmunol
4 J Neurol
2 J Pediatr Endocrinol Metab
2 Kidney Int
2 Mult Scler
1 Neurol Clin Pract
1 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Kidney Dis

  1. WANG CS, Glenn DA, Helmuth M, Smith AR, et al
    Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study.
    Am J Kidney Dis. 2024;83:37-46.
    PubMed         Abstract available

  2. RUGGENENTI P, Reinhard L, Ruggiero B, Perna A, et al
    Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.
    Am J Kidney Dis. 2023 Dec 25:S0272-6386(23)00993.
    PubMed         Abstract available


    Ann Neurol

  3. NICHOLAS R, Magliozzi R, Marastoni D, Howell O, et al
    High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective post-mortem cohort study.
    Ann Neurol. 2023 Dec 27. doi: 10.1002/ana.26870.
    PubMed         Abstract available

  4. VILLACIEROS-ALVAREZ J, Espejo C, Cobo-Calvo A
    Reply to "Myelin Oligodendrocyte Glycoprotein Antibody-Positive Patients Meeting the 2017 McDonald Criteria for Multiple Sclerosis: Challenges in Diagnosis and Treatment Decisions".
    Ann Neurol. 2023 Dec 11. doi: 10.1002/ana.26856.
    PubMed        


    J Autoimmun

  5. SHAO T, Hsu R, Rafizadeh DL, Wang L, et al
    The gut ecosystem and immune tolerance.
    J Autoimmun. 2023;141:103114.
    PubMed         Abstract available

  6. GUO Z, Yiu N, Hu Z, Zhou W, et al
    Alterations of fecal microbiome and metabolome in pemphigus patients.
    J Autoimmun. 2023;141:103108.
    PubMed         Abstract available

  7. GAO L, Zhang W, Zhang L, Gromova B, et al
    Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis.
    J Autoimmun. 2023;143:103162.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  8. PAPARODIS R, Livadas S, Karvounis E, Bantouna D, et al
    Elevated Preoperative TPO Ab Titers Decrease Risk for DTC in a Linear Fashion: A Retrospective Analysis of 1635 Cases.
    J Clin Endocrinol Metab. 2023;109:e347-e355.
    PubMed         Abstract available

  9. OKSNES M, Husebye ES
    Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults.
    J Clin Endocrinol Metab. 2023;109:269-278.
    PubMed        

  10. KRISTENSEN KB, Ranjan AG, McCarthy OM, Holst JJ, et al
    Effects of a low-carbohydrate-high-protein pre-exercise meal in type 1 diabetes - a randomised, crossover trial.
    J Clin Endocrinol Metab. 2023 Jul 18:dgad427. doi: 10.1210.
    PubMed         Abstract available

  11. HARTMANN B, Longo M, Mathiesen DS, Hare KJ, et al
    Signs of a Glucose and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2023 Jul 19:dgad431. doi: 10.1210.
    PubMed         Abstract available

  12. ETTINGER RA, Buitinga M, Vandamme C, Afonso G, et al
    Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study.
    J Clin Endocrinol Metab. 2023 Jul 20:dgad434. doi: 10.1210.
    PubMed         Abstract available

  13. ZHAO L, Li W, Liu L, Duan L, et al
    Clinical Features and Outcome Analysis of Type B Insulin Resistance Syndrome: A Single-Center Study in China.
    J Clin Endocrinol Metab. 2023;109:e175-e181.
    PubMed         Abstract available

  14. BELLINI S, Guarrera S, Matullo G, Schalkwijk C, et al
    Serum MicroRNA-191-5p Levels in Vascular Complications of Type 1 Diabetes: the EURODIAB Prospective Complications Study.
    J Clin Endocrinol Metab. 2023 Aug 8:dgad468. doi: 10.1210.
    PubMed         Abstract available

  15. FISKER FA, Voss TS, Svart MV, Kampmann U, et al
    Insulin signaling is preserved in skeletal muscle during early diabetic ketoacidosis.
    J Clin Endocrinol Metab. 2023 Aug 9:dgad464. doi: 10.1210.
    PubMed         Abstract available

  16. BILLINGS LK, Shi Z, Wei J, Rifkin AS, et al
    Utility of polygenic scores for differentiating diabetes diagnosis among patients with atypical phenotypes of diabetes.
    J Clin Endocrinol Metab. 2023 Aug 10:dgad456. doi: 10.1210.
    PubMed         Abstract available

  17. PARK J, Ntelis S, Yunasan E, Downton KD, et al
    Glucagon-like peptide 1 Analogues as Adjunctive Therapy for Patients with Type 1 Diabetes: an Updated Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2023 Aug 10:dgad471. doi: 10.1210.
    PubMed         Abstract available

  18. HITT TA, Hannon TS, Magge SN
    Approach to the Patient with Youth-Onset Type 2 Diabetes.
    J Clin Endocrinol Metab. 2023 Aug 16:dgad482. doi: 10.1210.
    PubMed         Abstract available

  19. DOUGLAS RS, Couch S, Wester ST, Fowler BT, et al
    Efficacy and Safety of Teprotumumab in Thyroid Eye Disease Patients with Long Duration and Low Disease Activity.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad637. doi: 10.1210.
    PubMed         Abstract available


    J Neuroimmunol

  20. LI HY, Xia M, Song M, Xie Y, et al
    Rs1800629 polymorphism in TNF-alpha is associated with the susceptibility and initial short-term glucocorticoids efficacy in myasthenia gravis patients.
    J Neuroimmunol. 2023;387:578269.
    PubMed         Abstract available

  21. TESFAGIORGIS Y, Kemal EA, Craig HC, Parham KA, et al
    Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity.
    J Neuroimmunol. 2023 Dec 15:578267. doi: 10.1016/j.jneuroim.2023.578267.
    PubMed         Abstract available


    J Neurol

  22. IAFFALDANO P, Lucisano G, Guerra T, Patti F, et al
    Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.
    J Neurol. 2023 Dec 22. doi: 10.1007/s00415-023-12137.
    PubMed         Abstract available

  23. ANDORRA M, Freire A, Zubizarreta I, de Rosbo NK, et al
    Predicting disease severity in multiple sclerosis using multimodal data and machine learning.
    J Neurol. 2023 Dec 22. doi: 10.1007/s00415-023-12132.
    PubMed         Abstract available

  24. LIU M, Ren H, Wang L, Fan S, et al
    Prognostic and relapsing factors of primary autoimmune cerebellar ataxia: a prospective cohort study.
    J Neurol. 2023 Dec 23. doi: 10.1007/s00415-023-12128.
    PubMed         Abstract available

  25. AZZIMONTI M, Margoni M, Zanetta C, Genovese F, et al
    Tumefactive demyelinating lesions: a challenging first manifestation of multiple sclerosis.
    J Neurol. 2023 Dec 28. doi: 10.1007/s00415-023-12164.
    PubMed        


    J Pediatr Endocrinol Metab

  26. BEN RABEH R, Bouzidi A, Hamdi R, Missaoui N, et al
    Unusual onset of Graves' disease associated with thymic hyperplasia in a 5-year-old girl with congenital bilateral clinical anophthalmia: diagnostic and therapeutic challenges.
    J Pediatr Endocrinol Metab. 2023 Dec 27. doi: 10.1515/jpem-2023-0331.
    PubMed         Abstract available

  27. SIVAKUMAR RR, Chinnaiah Govindareddy D, Sahoo J, Bobby Z, et al
    Effect of daily zinc supplementation for 12 weeks on serum thyroid auto-antibody levels in children and adolescents with autoimmune thyroiditis - a randomized controlled trial.
    J Pediatr Endocrinol Metab. 2024 Jan 1. doi: 10.1515/jpem-2023-0165.
    PubMed         Abstract available


    Kidney Int

  28. KISTLER AD, Salant DJ
    Complement Activation and Effector Pathways in Membranous Nephropathy.
    Kidney Int. 2023 Dec 21:S0085-2538(23)00868-2. doi: 10.1016/j.kint.2023.
    PubMed         Abstract available

  29. RIVEDAL M, Mikkelsen H, Marti HP, Liu L, et al
    Glomerular transcriptomics predicts long term outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy.
    Kidney Int. 2023 Dec 26:S0085-2538(23)00920-1. doi: 10.1016/j.kint.2023.
    PubMed         Abstract available


    Mult Scler

  30. PARCIAK T, Geys L, Helme A, van der Mei I, et al
    Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force.
    Mult Scler. 2023 Dec 23:13524585231216004. doi: 10.1177/13524585231216004.
    PubMed         Abstract available

  31. DOBSON R, Holden D, Vickaryous N, Bestwick J, et al
    A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis.
    Mult Scler. 2023 Dec 22:13524585231215268. doi: 10.1177/13524585231215268.
    PubMed         Abstract available


    Neurol Clin Pract

  32. KELLY EE, Engel C, Pearsall R, Brenton JN, et al
    Multiple Sclerosis and Family Planning: A Survey Study of the Patient Experience.
    Neurol Clin Pract. 2024;14:e200222.
    PubMed         Abstract available


    Thyroid

  33. PARK SK, Ryoo JH, Kim MH, Jung JY, et al
    Association between eight autoimmune diseases and thyroid cancer: A Nationwide Cohort Study.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0353.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.